首页> 外文期刊>Japanese Journal of Pharmacology >Inhibitory Effect of 4-Acylaminophenol Derivatives (T-0799 and T-0757), Novel Lipoxygenase Inhibitors, on Arachidonic Acid-Induced Infiltration of Polymorphonuclear Leukocytes in Rat Skin
【24h】

Inhibitory Effect of 4-Acylaminophenol Derivatives (T-0799 and T-0757), Novel Lipoxygenase Inhibitors, on Arachidonic Acid-Induced Infiltration of Polymorphonuclear Leukocytes in Rat Skin

机译:新型脂氧合酶抑制剂4-酰基氨基苯酚衍生物(T-0799和T-0757)对花生四烯酸诱导的大鼠皮肤多形核白细胞浸润的抑制作用

获取原文
获取外文期刊封面目录资料

摘要

References(20) Cited-By(1) Effects of 4-acylaminophenol derivatives, novel 5-lipoxygenase inhibitors, on the neutrophil infiltration in arachidonic acid (AA) (10 mg/site)-induced skin inflammation in rats were examined. Myeloperoxidase (MPO) activity in the skin lesion, used as an indicator of neutrophil infiltration, was significantly increased after intradermal injection of AA. Dual inhibitors of cyclooxygenase and 5-lipoxygenase, phenidone (100 mg/kg × 2, i.p. and p.o.) and BW-755C (50 mg/kg × 2, p.o.), and 5-lipoxygenase inhibitors, AA-861 (100 mg/kg × 2, i.p.) and the 4-acylaminophenol derivatives T-0799 and T-0757 (10-100 mg/kg × 2, p.o.), inhibited the increase in MPO activity 5 hr after AA-injection, but the cyclooxygenase inhibitor indomethacin (5 mg/kg, i.p.) showed no effect. These results suggest that products of lipoxygenase, but not of cyclooxygenase, are involved in the MPO activity increase (i.e., neutrophil infiltration), and that this model is useful for in vivo evaluation of 5-lipoxygenase inhibitors. It is suggested that the 4-acylaminophenol derivatives may be useful as orally active drugs for treatment of some leukotriene-mediated diseases.
机译:参考文献(20)引用了(1)研究了新型5-脂氧合酶抑制剂4-酰基氨基苯酚衍生物对花生四烯酸(AA)(10 mg /位)诱导的大鼠皮肤炎症中性粒细胞浸润的影响。皮内注射AA后,皮肤病变中的髓过氧化物酶(MPO)活性被用作中性粒细胞浸润的指示剂,其活性显着增加。环氧合酶和5-脂氧合酶的双重抑制剂,菲尼酮(100 mg / kg×2,ip和po)和BW-755C(50 mg / kg×2,ip)和5-脂氧合酶抑制剂AA-861(100 mg / kg×2,ip)和4-酰基氨基苯酚衍生物T-0799和T-0757(10-100 mg / kg×2,po)在AA注射后5小时抑制了MPO活性的增加,但是环加氧酶抑制剂吲哚美辛(5 mg / kg,ip)无效。这些结果表明脂氧化酶的产物而不是环氧化酶的产物参与MPO活性的增加(即中性粒细胞浸润),并且该模型可用于体内评估5-脂氧化酶抑制剂。建议4-酰基氨基苯酚衍生物可用作口服活性药物,以治疗某些白三烯介导的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号